SymmetryRx to lead the “Perfecting the Drug Sample Supply Chain” session at the 2023 Sharing Alliance
Drug sampling, from request to patient dispense, is highly regulated, especially to promote patient safety. Visibility into the full supply chain empowers regulatory performance for pharma and health system enterprise executive teams to achieve the highest standards of compliance.
Hal Walsh, CEO of SymmetryRx, will be joined by HCA’s Angela Dyer, PharmD, BCACP (AVP, Pharmacy) discuss opportunities to perfect the drug sample supply chain, including compliance and accountability in the request, dispense, and management processes. By adopting best practices, health systems enable measurability and ensure compliance with state pharmacy boards and Joint Commission accreditation requirements for their owned practices. Technology plays a key role in promoting oversight and superior risk management for executives at the health system enterprise level.
Walsh stated, “I am honored to return to the Sharing ConferenceTM to discuss the role of accountability and compliance in optimizing the drug sample management process. Removing the barriers and risks from the drug sampling process – and improving supply chain efficiency and compliance – is where government, providers, and pharma align because it’s about the patient.”
The Sharing ConferenceTM convenes pharmaceutical, medical device, and biotech compliance professionals annually. Attendees expand their knowledge and gain new perspectives on complying with the federal and state laws that affect their company's commercial operations. Conference topics include, but are not limited to, sample accountability and compliance, commercial operations, and compliance, transparency reporting, fraud and abuse, and data governance. With a specific mission of securing a safe and effective drug supply, the Sharing Conference educates leaders and promotes best practices within the industry.
To attend the session, register for The Sharing ConferenceTM at https://sharingalliance.org/. To learn more about SymmetryRx, visit https://www.symmetryrx.com/.
Recognized by pharma, practitioners, and health systems as the leader in drug sample management technology, SymmetryRx’s platforms enable the key elements of the drug sampling lifecycle, empowering superior patient care. With more than two decades of experience, a solid track record of growth, and partnerships with the largest and most influential players in the market, using 100% digital transactions, SymmetryRx is uniquely positioned at the forefront of the market to develop and deliver transformational technology across the industry.
| Pharma contact |
|---|
| Kimberly Middleton |
| SymmetryRx | Kimberly.middleton@symmetryRx.com |
| (815) 343-0864 |
| Health Systems contact |
|---|
| Dan Barton |
| SymmetryRx | dan.barton@symmetryRx.com |
| (978) 933-1230 |